Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2026
Microvascular health status as a novel predictor of acute side effects after radiotherapy: a quantitative analysis across three cancer sites.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Catalano Alessandra, Materne Sophie, Badenchini Fabio, Gioscio Eliana, Pisani Francesco, Possenti Luca, Avuzzi Barbara, Chiorda Barbara Noris, Rocca Eliana La, De Santis Maria Carmen, Franceschini Marzia, Iacovelli Nicola Alessandro, Cavallo Anna, Giandini Tommaso, Cicchetti Alessandro, Rancati Tiziana
Аннотация
PURPOSE: To quantitatively assess how microvascular conditions estimated via a non-invasive method can predict acute side effects after radiotherapy in patients with breast, prostate, and head and neck cancers.
MATERIALS AND METHODS: We studied 314 patients, assessing their MicroVascular Health Score (MVHS) before radiotherapy using a sublingual microscope that records videos of red blood cells in microvessels, analyses the microvasculature's functional and geometric properties, and calculates the MVHS. The MVHS was incorporated into a logistic model to predict the risk of developing acute radio-induced both alone and in combination with dose.
RESULTS: A clear quantitative association between MVHS and side effects was observed in the overall population (OR = 0.68, p = 0.001). A 1-unit decrease in MVHS was associated with a 31.9% increased risk of radiation-induced symptoms across cancer sites. In the breast subgroup, dose factors significantly affected side effect risk (OR for D200cc to the skin: 1.05 per 1 Gy; OR for D20cc: 1.14 per 1 Gy; OR for V20Gy: 1.01 per 1 cc; all p < 0.05). The D20cc model had the highest AUC (0.69), and adding MVHS further improved it to 0.76.
CONCLUSION: The study strongly linked microvascular health to the risk of acute radio-induced symptoms, suggesting that this could inform predictive models and customise treatments based on patient vascular status.
MATERIALS AND METHODS: We studied 314 patients, assessing their MicroVascular Health Score (MVHS) before radiotherapy using a sublingual microscope that records videos of red blood cells in microvessels, analyses the microvasculature's functional and geometric properties, and calculates the MVHS. The MVHS was incorporated into a logistic model to predict the risk of developing acute radio-induced both alone and in combination with dose.
RESULTS: A clear quantitative association between MVHS and side effects was observed in the overall population (OR = 0.68, p = 0.001). A 1-unit decrease in MVHS was associated with a 31.9% increased risk of radiation-induced symptoms across cancer sites. In the breast subgroup, dose factors significantly affected side effect risk (OR for D200cc to the skin: 1.05 per 1 Gy; OR for D20cc: 1.14 per 1 Gy; OR for V20Gy: 1.01 per 1 cc; all p < 0.05). The D20cc model had the highest AUC (0.69), and adding MVHS further improved it to 0.76.
CONCLUSION: The study strongly linked microvascular health to the risk of acute radio-induced symptoms, suggesting that this could inform predictive models and customise treatments based on patient vascular status.